Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Phreesia Inc (NY: PHR )

23.68 -0.63 (-2.59%)
Streaming Delayed Price Updated: 2:05 PM EDT, May 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Phreesia Inc

< Previous 1 2 3 4 5 6 7 Next >
Phreesia’s Alicia Cowley and Natasha Vega Named to MM+M’s ‘Women to Watch’ for 2024
From Phreesia
Via Business Wire
Phreesia Sets Release Date for Fiscal First Quarter 2025 Results
From Phreesia, Inc.
Via Business Wire
Phreesia Announces Jack Callahan as New Chief Technology Officer
From Phreesia
Via Business Wire
Analyst Expectations For Phreesia's Future
Via Benzinga
Recap: Phreesia Q4 Earnings
Via Benzinga
Phreesia Earnings Preview
Via Benzinga
Assessing Phreesia: Insights From 7 Financial Analysts
Via Benzinga
PHR Stock Earnings: Phreesia Misses EPS, Beats Revenue for Q4 2024
PHR stock results show that Phreesia missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2024. 
Via InvestorPlace
Phreesia Announces Fourth Quarter Fiscal 2024 Results
From Phreesia, Inc.
Via Business Wire
Earnings Scheduled For March 14, 2024
Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter. 
Via Benzinga
Phreesia’s Hilary Hatch Again Named to the 2024-2025 NQF Leadership Consortium
From Phreesia
Via Business Wire
New Data Shows That Engaging Patients with Relevant Cancer-Prevention Information During Check-In Increases Screening Rates
From Phreesia
Via Business Wire
Phreesia Sets Release Date for Fiscal Fourth Quarter 2024 Results
From Phreesia, Inc.
Via Business Wire
Bull Of The Day: Phreesia
The firm offers appointments, clinical support, integration, registration, patient activation, analytics and reports, revenue cycle, patient surveys, and privacy and security products. 
Via Talk Markets
5 Analysts Have This To Say About Phreesia
Via Benzinga
Phreesia Inc. (NYSE: PHR) Leading the Way in Wednesday Trading Based on Percentage Gain
Via Investor Brand Network
Phreesia Joins Call to Action to Improve Adult Vaccination Rates
From Phreesia
Via Business Wire
Phreesia’s Audrey Gato Named as a Top Woman Leader in SaaS
From Phreesia, Inc.
Via Business Wire
Phreesia’s Post-Script Engagement named one of PM360’s 2023 Most Innovative Technologies
From Phreesia
Via Business Wire
Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of AeroVironment, Inc. (NASDAQ: AVAV) moved lower during Wednesday’s session following second-quarter results. 
Via Benzinga
This Analyst Lowers Phreesia's Price Target Despite Projecting "Plenty Of Opportunity For Upside" - Read Why
Needham analyst Ryan MacDonald reiterated the Buy rating on Phreesia, Inc. (NYSE: PHR),  
Via Benzinga
THOR Industries Reports Upbeat Earnings, Joins Dave & Buster's Entertainment, Campbell Soup And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded higher, with the Dow Jones index gaining more than 50 points on Wednesday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Where Phreesia Stands With Analysts
Via Benzinga
SentinelOne To Rally Around 65%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
Recap: Phreesia Q3 Earnings
Via Benzinga
Earnings Preview For Phreesia
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Phreesia Announces Third Quarter Fiscal 2024 Results
From Phreesia, Inc.
Via Business Wire
Earnings Scheduled For December 5, 2023
Companies Reporting Before The Bell • Core & Main (NYSE:CNM) is expected to report quarterly earnings at $0.69 per share on revenue of $1.83 billion. 
Via Benzinga
CMS Includes the Patient Activation Measure in its Merit-Based Incentive Payment System Starting in 2024
From Phreesia
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.